2014
DOI: 10.1038/srep05952
|View full text |Cite
|
Sign up to set email alerts
|

NAD-dependent isocitrate dehydrogenase as a novel target of tributyltin in human embryonic carcinoma cells

Abstract: Tributyltin (TBT) is known to cause developmental defects as endocrine disruptive chemicals (EDCs). At nanomoler concentrations, TBT actions were mediated by genomic pathways via PPAR/RXR. However, non-genomic target of TBT has not been elucidated. To investigate non-genomic TBT targets, we performed comprehensive metabolomic analyses using human embryonic carcinoma NT2/D1 cells. We found that 100 nM TBT reduced the amounts of α-ketoglutarate, succinate and malate. We further found that TBT decreased the activ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
20
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 31 publications
(21 citation statements)
references
References 38 publications
(41 reference statements)
1
20
0
Order By: Relevance
“…4A). As previously reported, 100 nM TBT had a similar inhibitory effect (24.4%; Yamada et al, 2014). Treatment with apigenin (10 μM, 48 hr) decreased G1 phase ratio (58.6% decrease) and increased G2/M phase ratio (98.1% increase) (Figs.…”
Section: Tbt Induces G2/m Cell Cycle Arrest Via Nad-idhsupporting
confidence: 83%
“…4A). As previously reported, 100 nM TBT had a similar inhibitory effect (24.4%; Yamada et al, 2014). Treatment with apigenin (10 μM, 48 hr) decreased G1 phase ratio (58.6% decrease) and increased G2/M phase ratio (98.1% increase) (Figs.…”
Section: Tbt Induces G2/m Cell Cycle Arrest Via Nad-idhsupporting
confidence: 83%
“…Knockdown experiments were performed using Mfn1 shRNA lentiviruses from Sigma-Aldrich (MISSION shRNA), as previously reported49. A scrambled hairpin sequence was used as a negative control.…”
Section: Methodsmentioning
confidence: 99%
“…These results suggest that IDH is a novel target of TBTC (Yamada et al 2014). IDH is a mitochondrial enzyme from the tricarboxylic acid cycle that produces NADH.…”
Section: Resultsmentioning
confidence: 81%